• Users Online: 746
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 5  |  Issue : 4  |  Page : 389-394

Adiponectin level in hypertension


1 Clinical Pathology Department, Faculty of Medicine, Assiut University Heart Hospital, Assiut, Egypt
2 Cardiology Department, Faculty of Medicine, Assiut University Heart Hospital, Assiut, Egypt

Correspondence Address:
Fatma Salah El-Dein Hosney El-Naggar
Clinical Pathology Department, Faculty of Medicine, Assiut University Hospital, Assiut
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JCMRP.JCMRP_11_20

Rights and Permissions

Introduction Adiponectin is a hormone, secreted mainly by adipocytes. Despite accumulating experimental evidence on the etiological role of adiponectin in hypertension (HTN), data on plasma adiponectin level and HTN in humans are inconsistent and dose–response relationship has not been established. Aim To estimate and evaluate the level of adiponectin in patients with different stages of HTN and evaluate the relationship between adiponectin level in hypertensive patients in the presence or absence of metabolic syndrome. Patients and methods This work was carried out at the Clinical Pathology and Cardiology Departments at Assiut University Hospital. It included two groups of individuals: 60 patients with primary HTN (the patient group) and 20 age-matched and sex-matched apparently healthy individuals (the control group). Results Plasma adiponectin level was significantly lower in patients with HTN in comparison to the control group. Adiponectin levels in patients with stage 2 HTN was statistically insignificantly higher than those with stage 1 HTN and the adiponectin level was statistically insignificantly higher in stage 1 hypertensive patients compared with prehypertensive patients. Adiponectin level was significantly lower in male hypertensive patients with metabolic syndrome in comparison to male hypertensive patients without metabolic syndrome. The predictive value of adiponectin for the occurrence of HTN was 2.63 ng/ml, with 90% sensitivity and 35% specificity; the area under the receiver operating characteristic curve was 0.65 and P value of 0.03. Conclusion The low level of plasma adiponectin is an independent predictive factor for HTN even with the presence or absence of metabolic syndrome.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed36    
    Printed4    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal